Lorus Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lorus Therapeutics Inc
CIK #0000882361
EDGAR Form CIK 2011 - 2026
10-K [0000882361]
10-Q [0000882361]
3 [0000882361]
4 [0000882361]
6-K [0000882361]
8-K [0000882361]
D [0000882361]
SC 13D [0000882361]
SC 13G [0000882361]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bleichroeder LP Aptose Biosciences Inc [2025-02-13]
Armistice Capital LLC Aptose Biosciences Inc [2024-11-14]
Hanmi Pharmaceutical Co Ltd Aptose Biosciences Inc [2023-09-12]
Fletcher Aaron GL Aptose Biosciences Inc [2023-01-17]
OrbiMed Capital LLC Aptose Biosciences Inc [2021-02-12]
Nantahala Capital Management LLC Aptose Biosciences Inc [2020-02-14]
Consonance Capital Management LP Aptose Biosciences Inc [2020-02-14]
Opaleye Management Inc Aptose Biosciences Inc [2019-12-27]
Wilson Donald R Jr Aptose Biosciences Inc [2019-02-12]
Lytton Laurence W Aptose Biosciences Inc [2017-06-09]
View All
Form 3/4/5 Subject 2011 - 2026
Lorus Therapeutics Inc
Seizinger Bernd R
Whitehead Warren
Vincent Mark D
Rice William G
Platzer Erich
Payne Fletcher
Bejar Rafael
Burger Denis R
Hanmi Pharmaceutical Co Ltd
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lorus Therapeutics Inc APTO
Common Shares
2024-11-25 Buy 100,000 $0.20 20,000
Lorus Therapeutics Inc APTO
Warrants · derivative
2024-11-25 Buy 50,000
Lorus Therapeutics Inc APTO
Employee Stock Option (Right to Buy) · derivative
2024-02-05 Grant 70,000 $0.00
Lorus Therapeutics Inc APTO
Director Stock Option (Right to Buy) · derivative
2024-02-05 Grant 3,333 $0.00
Lorus Therapeutics Inc APTO
Director Stock Option (Right to Buy) · derivative
2024-02-05 Grant 3,333 $0.00
Lorus Therapeutics Inc APTO
Director Stock Option (Right to Buy) · derivative
2024-02-05 Grant 3,333 $0.00
Lorus Therapeutics Inc APTO
Director Stock Option (Right to Buy) · derivative
2024-02-05 Grant 3,333 $0.00
Lorus Therapeutics Inc APTO
Director Stock Option (Right to Buy) · derivative
2024-02-05 Grant 3,333 $0.00
Lorus Therapeutics Inc APTO
Director Stock Options (Right to Buy) · derivative
2024-02-05 Grant 3,333 $0.00
Lorus Therapeutics Inc APTO
Employee Stock Option (Right to Buy) · derivative
2024-02-05 Grant 55,000 $0.00
Lorus Therapeutics Inc APTO
Employee Stock Option (Right to Buy) · derivative
2024-02-05 Grant 11,000 $0.00
Lorus Therapeutics Inc APTO
Employee Stock Option (Right to Buy) · derivative
2024-02-05 Grant 35,000 $0.00
Lorus Therapeutics Inc APTO
Common Shares
2023-09-22 Buy 17,000 $3.14 53,380
Lorus Therapeutics Inc APTO
Employee Stock Option · derivative
2023-01-19 Grant 200,000 $0.00
Lorus Therapeutics Inc APTO
Common Shares
2023-01-19 Grant 100,000 $0.00
Lorus Therapeutics Inc APTO
Common Shares
2023-01-19 Grant 150,000 $0.00
Lorus Therapeutics Inc APTO
Common Shares
2023-01-19 Grant 100,000 $0.00
Lorus Therapeutics Inc APTO
Common Shares
2023-01-19 Grant 100,000 $0.00
Lorus Therapeutics Inc APTO
Director Option Grant · derivative
2023-01-19 Grant 100,000 $0.00
Lorus Therapeutics Inc APTO
Director Stock Option (Right to Buy) · derivative
2023-01-19 Grant 100,000 $0.00
showing 20 of 139 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com